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Abstract
Introduction: Photobiomodulation (PBM) is known as low-level laser (or light) therapy and is 
applied in different fields of medicine. However, it is required that its molecular and cellular 
mechanism be investigated. This study aims to assess the neuroprotective properties of PBM in 
the rat retina.
Methods: GSE22818 was downloaded from Gene Expression Omnibus (GEO) and the regulation 
of the significant differentially expressed genes (DEGs) which are produced by light damage in 
the rat retina by the pretreatment of PBM application was assessed via network analysis and gene 
ontology enrichment. 
Results: The 78 produced DEGs by light-damage in the rat retina were protected via PBM 
pretreatment action. Among these determined DEGs, 53 individuals were included in the main 
connected component of the constructed protein-protein interaction (PPI) network. Ccl2, Icam1, 
Cxcl10, Timp1, and Fos were determined as hub nodes. Eight clusters including 26 regulated 
biochemical pathways by PBM pretreatment were identified. The critical DEGs based on the 
action maps were introduced.
Conclusion: The finding indicates that PBM treatment protects rat retina against light damage via 
the prevention of  Fos, Ccl2, Icam1, Cxcl10, and Myc dysregulation. 
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Introduction
Photobiomodulation (PBM) is considered as low-level 
laser (or light) therapy utilized in medicine.1 PBM has 
been known for almost 50 years; therefore, it is expected 
that it should gain widespread acceptance, but due to 
uncertainty about its action mechanism in the molecular, 
cellular, and also tissue levels, it is not known as a 
common method in medicine.2 Different mechanisms 
including effectiveness in the production of ATP, calcium, 
nitric oxide, and to some extent, types of reactive oxygen 
are suggested for PBM. In addition, the mitochondrial 
cytochrome c oxidase and Ca2+ channels are recognized as 
the main receiver of these photons. PBM is used in various 
fields such as stimulating healing, relieving pain, and 
reducing inflammation.1 The usage of PBM has gained 
considerable attention in the field of ophthalmology 
recently due to its novel non-invasive and beneficial 
role in cellular regenerative functions.3 Retinal therapy 
is one of the fields wherein PBM is used for its injuries. 
Inflammation, oxidative damage, and dysfunctional 
mitochondria are the main processes of retinal injuries 
and diseases. Therefore, targeting these causes could be 
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a promising strategy for the recovery of the retina by 
such a method as PBM therapy.4 In other words, PBM 
could increase the chance of recovery for mitochondrial 
dysfunction, a reduction of cell death, and an increment 
of cytoprotective factors.5 For instance, in a study by 
Eells et al, the methanol damage to the retina could be 
alleviated by PBM therapy.6 Other studies also showed that 
exposure to this wavelength could have protective effects 
on retinal aging and degenerative diseases.4,7 To better 
understand the potential impacts of this type of laser 
therapy and to improve its clinical applications, molecular 
studies in terms of transcriptome evaluation could be 
important.8 What is more, bioinformatics evaluation 
by the application of protein-protein interaction (PPI) 
network analysis could add more worthy aspects to find 
key genes in the underlying mechanisms of this method 
of therapy.9 In such a study, large numbers of genes are 
screened to find the critical individuals that play a crucial 
role in the treated samples. Besides, network analysis 
gene ontology can provide useful information about the 
function of the differentially expressed genes (DEGs) 
to understand the molecular mechanism of the applied 
therapeutic method.10-12 The aim of the present paper 
was to detect central genes through network exploration 
to better define the mechanisms of the neuroprotective 
effect of PBM on the rat retina. 
Materials and Methods
GSE22818 (https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE22818) entitled “Comparison of Saffron 
and Photobiomodulation on the light damaged rat 
retina” was downloaded from GEO. The document was 
published as “Gene and noncoding RNA regulation 
underlying photoreceptor protection: microarray study 
of dietary antioxidant saffron and photobiomodulation 
in rat retina.”8 GSM563898-900 and GSM563907-9 were 
selected as normal and light-damage samples respectively. 
GSM563901-3 and GSM563910-12 were considered 
as PBM and PBM+light-damage groups respectively. 
The albino Sprague Dawley rats raised in dim cyclic 
illumination (12 h 5 lux, 12 h darkness) were considered 
as normal and the challenged individuals by 24h exposure 
to bright (1000 lux) light were regarded as light damage. 
The normal ones which were treated with pbm (10 J/
cm2 at the eye, daily for 5d) were nominated as the PBM 
group. The fourth group (PBM+light-damage group) 
were the rats of the PBM group which were irradiated by 
24 h exposure to bright (1000 lux) light.8
The gene expression profiles of control and light damage 
and also PBM and PBM+light-damage were matched via 
box plot analysis by the use of GEO2R software. The top 
250 DEGs based on P valve (small to large) were extracted 
from each analysis by GEO2R. Considering fold change 
>2 and P value ≤0.01, the significant characterized DEGs 
were a candidate for more analysis. Three categories of 
DEGs were determined; first the common DEGs between 
the two analysis, second the DEGs that existed in the 
control and light-damage analysis but were absent in 
the PBM and PBM+light-damage analysis, and third the 
DEGs of PBM and PBM+light-damage analysis which 
were not found in the control and light-damage analysis. 
The first group is the dis-regulated genes by light-damage 
and is not protected by PBM pretreatment. The second 
class refers to the genes that can be dysregulated by light-
damage but are protected by PBM pretreatment. Finally, 
the third set of genes is the dis-regulated genes by PBM. 
The second group of genes (the DEGs that existed in 
the control and light-damage analysis but were absent in 
the PBM and PBM+light-damage analysis) was selected 
to screen via PPI network analysis by using Cytoscape 
software.13 The genes were imported in Cytoscape and 
included in a network via the “protein query” of the 
STRING database. Due to poor interaction between the 
query genes, the 20 first neighbors of the nodes were 
added to the DEGs from the STRING database. The 
main connected component of the constructed network 
was analyzed by “Network analyzer”, an application 
of Cytoscape software. About 10% of top nodes of the 
main connected component based on degree value were 
selected among the queried DEGs (not including the first 
neighbors) as hub-nodes. 
The elements of the main connected component 
without the added first neighbors were investigated via 
the ClueGO application of Cytoscape14 to find the related 
biochemical pathways from the Kyoto Encyclopedia 
of Genes and the Genomes (KEGG) database. The 
determined pathways were clustered to find the crucial 
classes related to the neuroprotective property of PBM 
treatment. To screen the queried genes of the main 
connected component, the DEGs were assessed via the 
CluePedia plugin of Cytoscape software.15 Activation, 
inhibition, and expression actions were mapped and the 
critical DEGs were introduced.
Results
The gene expression profiles of the control group and the 
treated group with light damage were matched statistically 
(see Figure 1). Totally 250 genes were identified as DEGs 
based on statistically significant analysis by GEO2R 
software. Considering fold change ≥2 and P value <0.01, 
119 characterized significant DEGs were identified as the 
affected genes by light damage in rat retina.
Similarly, the gene expression profiles of the PBM-
treated samples versus the group treated with PBM plus 
light damage were analyzed statistically. The matched 
samples are presented in Figure 2. All profiles were 
characterized by the median value of 6 (see Figures 1 and 
2). As the analysis for the previous two groups, the 50 
significant DEGs referring to the effect of damage light 
on the PBM treated rats remained.
As it was analyzed, light damage in the absence of PBM 
treatment changed the gene expression of 119 genes 
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differentially, but in the presence of PBM action, 50 DEGs 
were identified. It can be concluded that the 50 DEGs can 
be grouped as the first class of DEGs (including 39 DEGs) 
that are common between the two analysis (refer to the 
light damage in the presence and absence of PBM) and 
the other (11 DEGs) which refer to the induced alterations 
by PBM. Simply it is concluded that the 39 DEGs are 
the affected genes by light damage in the presence and 
absence of PBM treatment and the 11 DEGs refer to the 
net effect of PBM action. After the deletion of the 39 
DEGs, 80 genes remained as the effect of light damage on 
the retina in the absence of PBM treatment. On the other 
hand, PBM treatment protects the retina by protecting 
the 80 genes from light damage. We consider these 80 
genes as a candidate for more analysis to understand 
the neuroprotective activity of PBM treatment against 
light damage. Among 80 DEGs two genes included 2 
isoforms; ladinin1 (Lad1) and methylenetetrahydrofolate 
dehydrogenase (NADP+ dependent) 2 (Mthfd2). The 78 
DEGs were included in the PPI network to screen the 
gene to find the central individuals. 
The network was constructed and the main connected 
component included 46 nodes with 169 edges and the 32 
remained nodes appeared as isolated or paired in double 
or triple groups. The poor interaction between the nodes 
implied adding 10 first neighbors to the DEGs. The main 
connected component of the new network includes 57 
nodes (47 DEGs and 10 added first neighbors) and 465 
connections. However, to improve connections between 
the nodes, 20 first neighbors were finally added to the 
queried DEGs. Adding more than 20 neighbors to 
Figure 1. Box Plot Analysis to Match the Gene Expression Profiles of 
Control and Light Damage Treated Samples. Data obey median centered 
distribution.
Figure 2. Box Plot Analysis to Match the Gene Expression Profiles of the 
PBM-Treated Samples Versus the Group Treated With PBM Plus Light 
Damage. Data obey median centered distribution.
Figure 3. The Main Connected Component of the PPI Network of PBM 
Neuroprotective Effect on the Rat Retina Against Light Damage. The nodes 
are laid out based on degree value. Green to red refers to the increment 
of degree value.
the queried DEGs had no effect on the promotion of 
connections between the nodes. As it is depicted in Figure 
3, the main connected component of the network in the 
case of adding 20 first neighbors included 73 nodes (53 
queried DEGs plus 20 first neighbors) and 816 edges. The 
hub nodes were selected among the queried DEGs. About 
10% of top nodes based on degree value were identified 
as hub nodes. The properties of hub nodes are presented 
in Table 1. In this table, degree (D) value, betweenness 
centrality (BC), closeness centrality (CC), and stress as 
the four important central parameters are presented for 
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the nodes of the network.
Since among 78 queried DEGs, 53 genes were connected 
to each other, activation, inhibition, and expression 
actions were investigated for these DEGs. As it is shown in 
Figures 4-6, 28, 17, and 19 DEGs were connected to each 
other in the activation, inhibition, and expression maps 
respectively. Biochemical pathway analysis for the 53 
Table 1. Properties of the Hub Nodes of the Main Connected Component
Gene Description D BC CC S
Ccl2
Immediate-early serum-responsive protein JE; Chemotactic factor that attracts monocytes, but not neutrophils; it 
belongs to the intercrine beta (chemokine CC) family.
41 0.007 0.69 610
Icam1
Intercellular adhesion molecule 1; During leukocyte trans-endothelial migration, ICAM1 engagement promotes the 
assembly of endothelial apical cups; it belongs to the immunoglobulin superfamily. 
41 0.010 0.69 738
Cxcl10
10 kDa interferon gamma-induced protein; In addition to its role as a pro-inflammatory cytokine, it may 
participate in T-cell effector function and perhaps T-cell development.
39 0.026 0.67 938
Timp1
Tissue inhibitor of metalloproteinases 1; It functions as a growth factor that regulates cell differentiation, migration 
and cell death and activates cellular signaling cascades via CD63 and ITGB1. It plays a role in integrin signaling. 
Also, it stimulates steroidogenesis by Leydig and ovarian granuloma cells.
37 0.017 0.66 936
Fos
FBJ osteosarcoma oncogene; It regulates TGF-beta- mediated signaling. It has a critical function in regulating the 
development of cells destined to form and maintain the skeleton. It is thought to have an important role in signal 
transduction, cell proliferation, and differentiation. 
34 0.054 0.64 1892
Abbreviations: D, degree; BC, betweenness centrality; CC, closeness centrality; S, stress.
Descriptions are obtained from STRING database and are summarized. 
Figure 4. Activation Map for the 53 Queried DEGs Participating in the Main 
Connected Component of the Constructed PPI Network. The direction of 
the arrows refers to the direction of activation.
Figure 6. Expression Map for the 53 Queried DEGs Participating in the 
Main Connected Component of the Constructed PPI Network. Bar and 
round tips refer to the direction of negative and positive co-expression.
Figure 5. Inhibition Map for the 53 Queried DEGs Participating in the 
Main Connected Component of the Constructed PPI Network. Bar tips 
refer to the direction of activation.
DEGs leads to determining 26 pathways from KEGG. The 
pathways are clustered in the 8 classes including classes 
1-5 that contain a single term and 6, 7, and 8 comprise 5, 
8, and 8 pathways respectively (see Figure 7 and Table 2). 
The Gene ontology term (GO Term), % associated genes 
(%AG), Number of genes, (NG), and associated genes 
found (AGF) which describe relationship between genes 
and the identified pathways are shown in Table 2.
Discussion
As it is depicted in Figures 1 and 2, the samples are 
comparable statistically. The distribution of gene 
expression amounts for both analyses are similar. It 
was found that PBM pretreatment prevented complete 
damage by light damage. Seventy-eight genes were 
protected from dysregulation by light damage. In the 
previous investigation, some benefits of PBM action 
were discovered. The reduction of pain, the increment of 
athletic performance, the stimulation of healing, neuron 
protection, and the positive role in cancer management 
are the benefits of PBM application; however, more 
investigations are recommended for the final confirmation 
of the positive role of PBM action in medicine.16,17 Network 
analysis revealed that the protection of Ccl2, Icam1, 
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Figure 7. 26 biochemical pathways categorized in 8 classes; related to the 
53 queried DEGs which were included in the main connected component 
of the PPI network. The pathways are obtained from KEGG and group 
P-Value corrected with Bonferroni step down ≤0.01 was considered. The 
highlighted pathways refer to the names of groups.
Table 2. Biochemical Pathways Related to the 53 queried DEGs Included in the Main Connected Component of the PPI Network
R GO Term % AG NG AGF
1 Cytokine-cytokine receptor interaction 4.43 12 [Ccl12, Ccl2, Ccl3, Ccl4, Clcf1, Csf1, Cxcl10, Il17rb, Il6st, Lif, Tnfrsf1a, Tnfrsf9]
2 NF-kappa B signaling pathway 5.77 6 [Birc3, Ccl4, Icam1, Myd88, Nfkb2, Tnfrsf1a]
3 Osteoclast differentiation 4.69 6 [Csf1, Fos, Fosl1, Junb, Nfkb2, Tnfrsf1a]
4 Complement and coagulation cascades 3.45 3 [Plat, Pros1, Serpine1]
5 IL-17 signaling pathway 7.69 7 [Ccl12, Ccl2, Cxcl10, Fos, Fosl1, Il17rb, Lcn2]
6
MAPK signaling pathway 3.07 9 [Csf1, Epha2, Fos, Gadd45g, Map3k6, Myc, Myd88, Nfkb2, Tnfrsf1a]
Prolactin signaling pathway 4.17 3 [Esr2, Fos, Irf1]
Colorectal cancer 4.05 3 [Fos, Gadd45g, Myc]
Small cell lung cancer 3.26 3 [Birc3, Gadd45g, Myc]
Breast cancer 3.31 5 [Esr2, Fos, Gadd45g, Myc, Nfkb2]
7
TNF signaling pathway 10.19 11 [Birc3, Ccl12, Ccl2, Csf1, Cxcl10, Fos, Icam1, Junb, Lif, Sele, Tnfrsf1a]
AGE-RAGE signaling pathway in diabetic 
complications
5.00 5 [Ccl12, Ccl2, Icam1, Sele, Serpine1]
Chagas disease (American trypanosomiasis) 6.93 7 [Ccl12, Ccl2, Ccl3, Fos, Myd88, Serpine1, Tnfrsf1a]
African trypanosomiasis 8.33 3 [Icam1, Myd88, Sele]
Malaria 12.24 6 [Ccl12, Ccl2, Icam1, Myd88, Sele, Selp]
Influenza A 3.57 6 [Ccl12, Ccl2, Cxcl10, Icam1, Myd88, Tnfrsf1a]
Rheumatoid arthritis 7.23 6 [Ccl12, Ccl2, Ccl3, Csf1, Fos, Icam1]
Fluid shear stress and atherosclerosis 5.63 8 [Ccl12, Ccl2, Fos, Hmox1, Icam1, Plat, Sele, Tnfrsf1a]
8
Toll-like receptor signaling pathway 5.05 5 [Ccl3, Ccl4, Cxcl10, Fos, Myd88]
Prolactin signaling pathway 4.17 3 [Esr2, Fos, Irf1]
Salmonella infection 5.13 4 [Ccl3, Ccl4, Fos, Myd88]
Pertussis 4.00 3 [Fos, Irf1, Myd88]
Chagas disease (American trypanosomiasis) 6.93 7 [Ccl12, Ccl2, Ccl3, Fos, Myd88, Serpine1, Tnfrsf1a]
Influenza A 3.57 6 [Ccl12, Ccl2, Cxcl10, Icam1, Myd88, Tnfrsf1a]
Breast cancer 3.31 5 [Esr2, Fos, Gadd45g, Myc, Nfkb2]
Rheumatoid arthritis 7.23 6 [Ccl12, Ccl2, Ccl3, Csf1, Fos, Icam1]
 The pathways are obtained from KEGG and group P-Value corrected with Bonferroni step down ≤0.01 was considered.
Cxcl10, Timp1, and Fos genes against light damage is an 
important beneficiary effect of PBM action on the retina. 
The mentioned genes are the critical elements of the 
analyzed network. As it is shown in Figure 3, all of these 
genes appear in the red color which corresponds to the 
high value of the degree. As it is depicted in Table 1, Ccl2, 
Icam1, and Cxcl10 are involved in the immunological 
activities and Timp1 and Fos play a role in the regulation 
of cell differentiation, cell migration, cell death, activation 
of several cellular signaling cascades, integrin signaling, 
stimulation of steroidogenesis by Leydig and ovarian 
granuloma cells, the regulation of TGF-beta-mediated 
signaling, the regulation of development of cells destined 
to form and maintain the skeleton, signal transduction, 
and cell proliferation. All five hub nodes are presented in 
the activation and expression maps and appear as critical 
elements of the activation and expression networks; 
however, only Fos, among the other hubs, is highlighted 
in the inhibition map. Hmox1 and Myc are the two non-
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hub DEGs that are presented in the activation, inhibition, 
and expression maps and issued important regulatory 
effects. Myc is a well-known oncogene which in humans 
is located on chromosome 8.18 Investigations indicate that 
Myc is frequently deregulated in different kinds of human 
cancers.19
As it is shown in Figure 7 and Table 2, 26 biochemical 
pathways which are related to the elements of the main 
connected component are identified. The cytokine-
cytokine receptor interaction including 12 DEGs (Ccl12, 
Ccl2, Ccl3, Ccl4, Clcf1, Csf1, Cxcl10, Il17rb, Il6st, Lif, 
Tnfrsf1a, and Tnfrsf9) is the largest pathway and Malaria 
with the maximum of “% associated genes” (12.24) is 
highlighted in Table 2. Fos, Ccl2, Icam1, Cxcl10, and 
Timp1 (the hub nodes) are involved in the 16, 12, 10, 6, 
and 0 pathways respectively. Myc and Hmox1 which were 
highlighted in the action maps are related to the 5 and 
1 pathways respectively. The maximum number of hub 
nodes which are presented in a certain pathway is 3. Each 
one of the “IL-17 signaling pathway”, “TNF signaling 
pathway”, “Influenza A”, and “Rheumatoid arthritis” 
includes 3 hub DEGs. There are only 2 pathways (about 
8% of the total pathways); “Small cell lung cancer” and 
“Complement and coagulation cascades” that are not 
related to the hub nodes. Based on the centrality analysis 
of the PPI network analysis, action map assessment, and 
gene ontology finding, it can be concluded that Fos, Ccl2, 
Icam1, Cxcl10, and Myc are the crucial genes which are 
related to the neuroprotective property of PBM treatment. 
Except Timp1, the important role of the other 4 central 
genes (Fos, Ccl2, Icam1, Cxcl10) was confirmed by gene 
ontology analysis. MYC was highlighted via action map 
analysis and gene ontology assessment; however, it was 
not included in the hub group of DEGs. Fos is presented 
in the 16 pathways (about 62% of all pathways) and 5 
clusters of 8 total clusters (again 62% of all clusters).
As it is reported, PBM with blue light leads to the down-
regulation of FBJ murine osteosarcoma viral oncogene 
homolog (FOS), interleukin 8 (IL8), and keratin 5 
(Krt5) in human keratinocytes. Also, in this research, 
it is concluded that the reduction of the TNF-signaling 
pathway is related to the absence of apoptosis after PBM 
action with blue light.20 The TNF-signaling pathway is 
highlighted in the present study as the largest pathway 
cluster and includes 4 hub DEGs (Ccl2, Cxcl10, Fos, and 
Icam1). Based on the investigation of Pansani et al, PBM 
decreases Ccl2 synthesis in human gingival fibroblasts and 
epithelial cells. These effects may play a role in decreasing 
tissue inflammatory response and also the improvement 
of wound healing of oral mucosal tissue.21 
Conclusion
The finding from this study indicates that PBM protects 
the rat retina against light damage via preventing the 
deregulation of many genes including Fos, Ccl2, Icam1, 
Cxcl10, and Myc which are the crucial individuals. The 
analysis revealed that the regulation of the Fos gene is an 
important prevention effect of the application of PBM on 
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